All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Marketed under New Animal Drug Application | NCIT_C73593 | [A category specifying that a product is marketed under a New Animal Drug Application.] |
| Marketed as Bulk Inactive Ingredient | NCIT_C73587 | [A category specifying that a product is marketed as a bulk inactive ingredient.] |
| Marketed as Bulk Ingredient | NCIT_C73626 | [A category specifying that a product is marketed as a bulk ingredient.] |
| Marketed under Conditional Approval of New Animal Drug Application | NCIT_C73588 | [A category specifying that a product is marketed under a conditional approval of a New Animal Drug Application.] |
| Vicriviroc | NCIT_C73589 | [A piperazine-based CCR5 receptor antagonist with activity against human immunodeficiency virus. Vicriviroc is designed to bind to CCR5 and inhibit the entry of HIV into CD4 cells.] |
| Anti-HIV Agent | NCIT_C1660 | [Any agent that prevents the human immunodeficiency virus (HIV) from reproducing.] |
| Marketed under Abbreviated New Animal Drug Application | NCIT_C73583 | [A category specifying that a product is marketed under an Abbreviated New Animal Drug Application.] |
| Marketed under Abbreviated New Drug Application | NCIT_C73584 | [A category specifying that a product is marketed under an Abbreviated New Drug Application.] |
| Marketed under Biologic License Application | NCIT_C73585 | [A category specifying that a product is marketed under a Biologic License Application.] |
| Marketed as Bulk Active Ingredient | NCIT_C73586 | [A category specifying that a product is marketed as a bulk active ingredient.] |
| Recurrent Ovarian Endometrioid Adenocarcinoma | NCIT_C150095 | [The reemergence of ovarian endometrioid adenocarcinoma after a period of remission.] |
| Recurrent Endometrioid Adenocarcinoma | NCIT_C158421 | [The reemergence of endometrioid adenocarcinoma after a period of remission.] |
| Recurrent Ovarian Adenocarcinoma | NCIT_C153614 | [The reemergence of ovarian adenocarcinoma after a period of remission.] |
| Refractory Ovarian Endometrioid Adenocarcinoma | NCIT_C150096 | [Ovarian endometrioid adenocarcinoma that is resistant to treatment.] |
| Refractory Ovarian Carcinoma | NCIT_C150091 | [Ovarian carcinoma that is resistant to treatment.] |
| Refractory Adenocarcinoma | NCIT_C159563 | [An adenocarcinoma that does not respond to treatment.] |
| Recurrent Endometrial Endometrioid Adenocarcinoma | NCIT_C150097 | [The reemergence of endometrial endometrioid adenocarcinoma after a period of remission.] |
| Refractory Endometrial Endometrioid Adenocarcinoma | NCIT_C150098 | [Endometrial endometrioid adenocarcinoma that is resistant to treatment.] |
| Refractory Endometrial Carcinoma | NCIT_C150093 | [Endometrial carcinoma that is resistant to treatment] |
| Refractory Female Reproductive System Carcinoma | NCIT_C152048 | [Female reproductive system carcinoma that is resistant to treatment.] |